The deleted in oral cancer (DOC1 aka CDK2AP1) tumor suppressor gene is downregulated in oral squamous cell carcinoma by multiple microRNAs
-
Published:2023-05-22
Issue:5
Volume:14
Page:
-
ISSN:2041-4889
-
Container-title:Cell Death & Disease
-
language:en
-
Short-container-title:Cell Death Dis
Author:
Stabile Roberto, Cabezas Mario RománORCID, Verhagen Mathijs P.ORCID, Tucci Francesco A.ORCID, van den Bosch Thierry P. P., De Herdt Maria J., van der Steen Berdine, Nigg Alex L., Chen Meng, Ivan Cristina, Shimizu Masayoshi, Koljenović Senada, Hardillo Jose A., Verrijzer C. Peter, Baatenburg de Jong Robert J., Calin George A.ORCID, Fodde RiccardoORCID
Abstract
AbstractCyclin-dependent kinase 2-associated protein 1 (CDK2AP1; also known as deleted in oral cancer or DOC1) is a tumor suppressor gene known to play functional roles in both cell cycle regulation and in the epigenetic control of embryonic stem cell differentiation, the latter as a core subunit of the nucleosome remodeling and histone deacetylation (NuRD) complex. In the vast majority of oral squamous cell carcinomas (OSCC), expression of the CDK2AP1 protein is reduced or lost. Notwithstanding the latter (and the DOC1 acronym), mutations or deletions in its coding sequence are extremely rare. Accordingly, CDK2AP1 protein-deficient oral cancer cell lines express as much CDK2AP1 mRNA as proficient cell lines. Here, by combining in silico and in vitro approaches, and by taking advantage of patient-derived data and tumor material in the analysis of loss of CDK2AP1 expression, we identified a set of microRNAs, namely miR-21-5p, miR-23b-3p, miR-26b-5p, miR-93-5p, and miR-155-5p, which inhibit its translation in both cell lines and patient-derived OSCCs. Of note, no synergistic effects were observed of the different miRs on the CDK2AP1–3-UTR common target. We also developed a novel approach to the combined ISH/IF tissue microarray analysis to study the expression patterns of miRs and their target genes in the context of tumor architecture. Last, we show that CDK2AP1 loss, as the result of miRNA expression, correlates with overall survival, thus highlighting the clinical relevance of these processes for carcinomas of the oral cavity.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference80 articles.
1. Todd R, McBride J, Tsujl T, Donoff RB, Nagai M, Chou MY, et al. Deleted in oral cancer‐1 (doc‐l), a novel oral tumor suppressor gene. FASEB J. 1995;9:1362–70. 2. Matsuo K, Shintani S, Tsuji T, Nagata E, Lerman M, Mcbride J, et al. p12DOC1, a growth suppressor, associates with DNA polymerase α/primase. FASEB J. 2000;14:1318–24. 3. Spruijt CG, Bartels SJJ, Brinkman AB, Tjeertes JV, Poser I, Stunnenberg HG, et al. CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex. Mol Biosyst. 2010;6:1700–6. 4. Reynolds N, Salmon-Divon M, Dvinge H, Hynes-Allen A, Balasooriya G, Leaford D, et al. NuRD-mediated deacetylation of H3K27 facilitates recruitment of polycomb repressive complex 2 to direct gene repression. EMBO J. 2012;31:593–605. 5. Deshpande AM, Dai YS, Kim Y, Kim J, Kimlin L, Gao K, et al. Cdk2ap1 is required for epigenetic silencing of Oct4 during murine embryonic stem cell differentiation. J Biol Chem. 2009;284:6043–7.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|